Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.42 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.42 |
| ▸ | TAS1R2 | Q8TE23 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 3/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | CYP2A6 | P11509 | 3/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.39 |
| ▸ | NPC1 | O15118 | 4/20 | 0.38 |
| ▸ | RAB9A | P51151 | 4/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | HCRTR1 | O43613 | 2/20 | 0.38 |
| ▸ | HCRTR2 | O43614 | 2/20 | 0.38 |
| ▸ | CNR2 | P34972 | 2/20 | 0.38 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.38 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.38 |
| ▸ | RELA | Q04206 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29374425 | 1.00 | TAS1R3 (0.42) | TAS1R3TAS1R1TAS1R2MEN1KMT2A | |
| SCHEMBL29372199 | 0.90 | MEN1 (0.38) | TAS1R3TAS1R1TAS1R2MEN1KMT2A | |
| SCHEMBL58468 | 0.90 | MEN1 (0.38) | TAS1R3TAS1R1TAS1R2MEN1KMT2A | |
| SCHEMBL5898571 | 0.87 | CNR2 (0.42) | MEN1KMT2APOLBGAANPC1 | |
| SCHEMBL28674909 | 0.84 | TAS1R3 (0.45) | TAS1R3TAS1R1TAS1R2POLBCYP2A6 | |
| SCHEMBL6469382 | 0.82 | S1PR4 (0.43) | MEN1KMT2AGAASMN1; SMN2 | |
| SCHEMBL2771807 | 0.80 | TAS1R3 (0.46) | TAS1R3TAS1R1TAS1R2MEN1KMT2A | |
| SCHEMBL58820 | 0.79 | TAS1R3 (0.43) | TAS1R3TAS1R1TAS1R2MEN1KMT2A | |
| SCHEMBL29375600 | 0.79 | TAS1R3 (0.43) | TAS1R3TAS1R1TAS1R2MEN1KMT2A | |
| SCHEMBL58579 | 0.77 | GAA (0.39) | TAS1R3TAS1R1TAS1R2MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 322 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12024136-B2 | Ultra-fast curing scratch-resistant headlight restoration coating | ILLINOIS TOOL WORKS INC. (US) | 2024-07-02 | — | — | US | claimed |
| EP-4286163-B1 | ELECTRON BEAM CURABLE INK, AND IMAGE RECORDING METHOD | FUJIFILM CORP (JP) | 2026-04-01 | — | — | EP | disclosed |
| EP-4514304-B1 | DENTAL COMPOSITION CONTAINING A RESORCINOL OR CATECHOL MOIETY CONTAINING COMPONENT AND USE THEREOF | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) | 2026-03-25 | — | — | EP | disclosed |
| US-12577340-B2 | Storage stable two-component dual cure dental composition | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) | 2026-03-17 | — | — | US | disclosed |
| EP-4681930-A1 | IMAGE RECORDING METHOD, METHOD FOR MANUFACTURING LAMINATE, AND IMAGE RECORDING APPARATUS | FUJIFILM Corporation (JP) | 2026-01-21 | — | — | EP | disclosed |
| US-20250375971-A1 | IMAGE RECORDING METHOD, MANUFACTURING METHOD OF LAMINATE, AND IMAGE RECORDING APPARATUS | FUJIFILM CORP (JP) | 2025-12-11 | — | — | US | disclosed |
| EP-4660262-A1 | ACTIVE ENERGY RAY-CURABLE INKJET INK, ACTIVE ENERGY RAY-CURABLE INK SET, AND IMAGE RECORDING METHOD | FUJIFILM Corporation (JP) | 2025-12-10 | — | — | EP | disclosed |
| US-20250340747-A1 | ACTIVE ENERGY RAY CURABLE TYPE INK JET INK, ACTIVE ENERGY RAY CURABLE TYPE INK SET, AND IMAGE RECORDING METHOD | FUJIFILM CORP (JP) | 2025-11-06 | — | — | US | disclosed |
| EP-4632021-A1 | ACTIVE ENERGY RAY-CURABLE INKJET INK, ACTIVE ENERGY RAY-CURABLE INK SET, AND IMAGE RECORDING METHOD | FUJIFILM Corporation (JP) | 2025-10-15 | — | — | EP | disclosed |
| EP-4329704-B1 | INITIATOR SYSTEM WITH POLYMERIZABLE THIOUREA COMPONENT, DENTAL COMPOSITION AND USE THEREOF | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) | 2025-10-08 | — | — | EP | disclosed |
| EP-0825201-B2 | Photocurable composition and curing process therefor | SHOWA DENKO KK (JP) | 2006-11-29 | — | — | EP | disclosed |
| US-7049350-B2 | Polymerizable compound, polymerizable composition and cured product containing the compound | SHOWA DENKO K.K. (JP) | 2006-05-23 | — | — | US | disclosed |
| US-20050221210-A1 | Electrophotographic photoconductor and image formation method, image formation apparatus, and process cartridge for image formation apparatus using the electrophotographic photoconductor | RICOH COMPANY, LTD. (JP) | 2005-10-06 | — | — | US | disclosed |
| US-20050185232-A1 | Volume hologram recording photosensitive composition and its use | NIPPON PAINT CO., LTD. (JP) | 2005-08-25 | — | — | US | disclosed |
| US-20040235980-A1 | Polymerizable compound, polymerizable composition and cured product containing the compound | SHOWA DENKO K.K. (JP) | 2004-11-25 | — | — | US | disclosed |
| EP-0825201-B1 | Photocurable composition and curing process therefor | SHOWA DENKO KK (JP) | 2002-02-27 | — | — | EP | disclosed |
| EP-1044777-A1 | Molding method for corrosion-resistant FRP | SHOWA DENKO KABUSHIKI KAISHA (JP) | 2000-10-18 | — | — | EP | disclosed |
| EP-0825201-A1 | Photocurable composition and curing process therefor | SHOWA DENKO KABUSHIKI KAISHA (JP) | 1998-02-25 | — | — | EP | disclosed |
| US-4792632-A | ADDITION POLYMER PHOTOINITIATORS | ESPE FABRIK PHARMAZEUTISCHER PRAPARATE GMBH (DE) | 1988-12-20 | — | — | US | disclosed |
| US-4737593-A | PHOTOINITIATORS FOR ADDITION POLYMERIZATION; DENTISTRY | Fabrik Pharmazeutischer Praparate (DE) | 1988-04-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12577340-B2 | Storage stable two-component dual cure dental composition | GPX4, SSRP1, H1-0 | TAS1R3 182/4885TAS1R1 73/4885TAS1R2 60/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.